Natco Pharma

BSE: 524816 | NSE: NATCOPHARM
Natco Pharma (CIN: L24230TG1981PLC003201) operates in the Pharmaceuticals industry and has been listed in the stock market since 11th Apr 1995. It currents trades on NSE with symbol NATCOPHARM and on BSE with scrip code 524816.
The registered office of the company is Natco House, Road No 2, Banjara Hills,Hyderabad,Telangana,500033.

The management team of Natco Pharma is led by V C Nannapaneni who is the Chairman & Managing Director. Other members of the management team consist of M Adinarayana (Designation:Company Secretary & Vice President (Legal & Corporate Affairs)), Rajeev Nannapaneni (Designation:Vice Chairman & Chief Executive Officer), Sridhar Sankararaman (Designation:Director), D. G. Prasad (Designation:Director), T V Rao (Designation:Director), Dr. Leela Digumarti (Designation:Director), P S R K Prasad (Designation:Director), S V V N Appa Rao (Designation:Chief Financial Officer), Dr. M. U. R. Naidu (Designation:Director), Dr. D. Linga Rao (Designation:Director & President (Technical Affairs)), .

The price and other financial information of Natco Pharma is as below -

BSE 572.10 -22.30 (-3.75%)

BSE

572.10 -22.30 (-3.75%)
Volume: 9,193.00
M. Cap: 10,524.00
P/E: 12.53
Prev. Close: 594.40
Day
52 Wk

NSE

575.15 -11.65 (-1.99%)
Volume: 2,00,909.00
M. Cap: 10,524.00
P/E: 12.53
Prev. Close: 586.80
Day
52 Wk

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 8,66,43,105 47.10
Foreign Institutions 4,38,18,948 23.82
General Public 3,26,30,740 17.74
NBFC and Mutual Funds 94,38,137 5.13
Others 72,30,974 3.93
ForeignPromoter 24,38,540 1.33
Financial Institutions 17,61,776 0.96
Total 18,39,62,220 100.01

NSE Trade Data

Trade Snapshot
VWAP 574.97
Face Value 2.00
Traded Volume (shares) 2,00,962.00
Traded Value (lacs) 1,155.47
Free Float Market Cap (Crs) 5,309.33
52 week high 848.30
52 week low 568.60
Lower Price Band 469.45
Upper Price Band 704.15
Security-wise Delivery Position
Quantity Traded 1,73,729.00
Deliverable Quantity (gross across client level) 84,875.00
% of Deliverable Quantity to Traded Quantity 48.85 %
Value at Risk (VaR in %)
Security VaR 7.44
Index VaR -
VAR Margin 7.50
Extreme Loss Rate 5.00
Adhoc Margin -
Applicable Margin Rate 12.50

Financial Data

Consolidated
Figures in crore 2018 2017 2016
Net Sales 2,184.80 2,020.20 1,042.30
Operating Profit 968.80 697.30 277.40
Other Income 40.40 13.90 11.80
Interest 15.40 18.50 22.90
Depreciation 66.20 54.40 50.80
Profit Before Tax 887.20 624.40 203.70
Tax 192.00 139.50 47.90
Profit After Tax 695.20 484.90 155.80
Share Capital 36.90 34.90 34.80
Reserves 3,035.30 1,614.40 1,260.90
Net Worth 3,072.20 1,649.30 1,295.70
Loans 206.40 244.50 125.90
Gross Block 1,407.60 1,158.70 983.30
Investments 76.50 32.20 22.20
Cash 183.70 35.80 45.20
Debtors 637.50 475.20 261.60
Net Working Capital 1,707.30 696.40 482.40
Operating Profit Margin (%) 44.34 34.52 26.61
Net Profit Margin (%) 31.82 24.00 14.95
Earning Per Share (Rs) 37.73 27.85 9.03
Dividend (%) 412.50 337.50 62.50
Dividend Payout 150.90 117.60 21.80
Standalone
Figures in crore 2018 2017 2016
Net Sales 2,091.30 1,958.00 1,059.20
Operating Profit 967.80 705.20 293.60
Other Income 39.40 13.20 12.90
Interest 14.70 17.50 21.90
Depreciation 65.50 53.60 50.20
Profit Before Tax 887.60 634.10 221.50
Tax 189.40 139.30 45.00
Profit After Tax 698.20 494.80 176.50
Share Capital 36.90 34.90 34.80
Reserves 3,088.50 1,664.80 1,301.50
Net Worth 3,125.40 1,699.70 1,336.30
Loans 206.20 243.50 123.50
Gross Block 1,399.60 1,151.00 975.90
Investments 149.60 94.80 93.80
Cash 172.10 25.10 40.20
Debtors 606.00 468.90 255.80
Net Working Capital 1,686.70 683.20 448.50
Operating Profit Margin (%) 46.28 36.02 27.72
Net Profit Margin (%) 33.39 25.27 16.66
Earning Per Share (Rs) 37.84 28.36 9.89
Dividend (%) 412.50 337.50 62.50
Dividend Payout 150.90 117.60 21.80
Dividend Declared (₹)
The company has declared dividend 15 times between 12 Nov 2007 and 21 Feb 2019, totaling Rs. 42.00 so far. The most dividend was declared on 21 Feb 2019 for Rs. 3.5.

Financial Data Graph

The peers of Natco Pharma are AUROPHARMA, GRANULES and PFIZER. You can get more detailed information on those company by clicking on the respective names.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*